XML 30 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Millions
Total
COMMON STOCK
ADDITIONAL PAID-IN CAPITAL
RETAINED EARNINGS
ACCUMULATED OTHER COMPREHENSIVE LOSS
TREASURY SHARES
NON-CONTROLLING INTERESTS
Balance, beginning of period at Dec. 31, 2021   $ 561 $ 1,112 $ 18,389 $ (4,575) $ (4,478) $ 213
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Change in accrued stock compensation costs     (145)        
Issuance of shares under stock compensation plans and employee stock purchase plans     59     91  
Net income attributable to the Company $ 1,086     1,071     15
Dividend equivalents declared       (4)      
Dividends declared       (540)      
Other comprehensive income (loss), net of tax (104)       (104)    
Purchase of treasury shares (500)         (500)  
Distributions and other changes             (9)
Balance, end of period at Mar. 31, 2022 $ 11,156 561 1,026 18,916 (4,679) (4,887) 219
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Dividends declared per share (in dollars per share) $ 1.07            
Balance, beginning of period at Dec. 31, 2022 $ 10,749 561 1,179 20,301 (5,314) (6,207) 229
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Change in accrued stock compensation costs     (190)        
Issuance of shares under stock compensation plans and employee stock purchase plans     75     120  
Net income attributable to the Company 1,252     1,235     17
Dividend equivalents declared       (4)      
Dividends declared       (583)      
Other comprehensive income (loss), net of tax 80       80    
Purchase of treasury shares (300)         (300)  
Distributions and other changes             (3)
Balance, end of period at Mar. 31, 2023 $ 11,196 $ 561 $ 1,064 $ 20,949 $ (5,234) $ (6,387) $ 243
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Dividends declared per share (in dollars per share) $ 1.18